Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01829516 · ClinicalTrials.gov registry record · Phase 4
Intranasal Oxytocin and Social Cognition, Implicit Preferences and Craving in Alcohol Drinkers
A Phase 4 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 32
- Enrollment target
NCT01829516 is a Phase 4 study that has completed, run by University of California, San Francisco. The registered enrollment target is 32 participants.
The verdict
NCT01829516, a Phase 4 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 32 participants
- Enrollment target
Study Summary
This is a randomized, placebo controlled, double blind crossover study of the effects of intranasal oxytocin on social cognition, implicit preferences and craving in moderate to heavy social alcohol drinkers.
Interventions
- DRUG Placebo
- DRUG Oxytocin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2013-05 |
| Est. Completion | 2014-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01829516
The ClinicalTrials.gov registry entry for NCT01829516 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01829516 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01829516 about?
NCT01829516 is a clinical study titled "Intranasal Oxytocin and Social Cognition, Implicit Preferences and Craving in Alcohol Drinkers". This is a randomized, placebo controlled, double blind crossover study of the effects of intranasal oxytocin on social cognition, implicit preferences and craving in moderate to heavy social alcohol drinkers.
What is the current status of trial NCT01829516?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 32 participants. The study started on 2013-05. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01829516?
The interventions under investigation include: Placebo (DRUG), Oxytocin (DRUG).
Who is sponsoring clinical trial NCT01829516?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.